ChemTrak Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ChemTrak

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DeadHead who wrote (30)	10/22/1996 10:54:00 AM
From: William Presti	of 48

Yesterday I had another conversation with a CMTR marketing representative. As I understood it (or assumed from the conversation), the Hp Chek test kit to be marketed through Astra/Merck would see production ramped up this 4th quarter. The reference to "full" production was an analytical leap on my part and was not so indicated by Chemtrak. With that said, I did ask about revenues for 3rd v.s. 4th quarter. While they could not comment on projections, they did indicate that revenues from Hp Chek should become apparent during the 4th quarter. My overall impression of the company's take on Hp Chek is that 1) they are very excited about it, and 2) it will be a consistent revenue producer. In addition, the latest Hp Chek going to production is apparently of even higher quality/accuracy then what was originally accepted by Astra/Merck. So, while this stock might not be a good pick for the faint of heart, I believe that the patient investor with a reasonable time table for investing in mind will be rewarded. So it is just a matter of time. Cholestrak + Hp Chek + expected approval on AWARE HIV home test kit + Japan's expected approval for the theophylline test kit for Jokoh + future products/developments and distribution partnerships = :))

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next